1. Lory, Philippe, Nicole, Sophie, Monteil, Arnaud. 2020. Neuronal Cav3 channelopathies: recent progress and perspectives. In Pflugers Archiv : European journal of physiology, 472, 831-844. doi:10.1007/s00424-020-02429-7. https://pubmed.ncbi.nlm.nih.gov/32638069/
2. Cai, Song, Gomez, Kimberly, Moutal, Aubin, Khanna, Rajesh. 2021. Targeting T-type/CaV3.2 channels for chronic pain. In Translational research : the journal of laboratory and clinical medicine, 234, 20-30. doi:10.1016/j.trsl.2021.01.002. https://pubmed.ncbi.nlm.nih.gov/33422652/
3. Guo, Ping, Hu, Shuiqing, Liu, Xiaohui, Fang, Qin, Wang, Yan. 2024. CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction. In Journal of translational medicine, 22, 390. doi:10.1186/s12967-024-05223-6. https://pubmed.ncbi.nlm.nih.gov/38671439/
4. Li, Xue, Hu, Chengyun, Luo, Shanshan, Jiang, Lai, Tang, Chaoliang. 2024. Cav3.2 deletion attenuates nonalcoholic fatty liver disease in mice. In Gene, 929, 148812. doi:10.1016/j.gene.2024.148812. https://pubmed.ncbi.nlm.nih.gov/39116959/
5. Dai, Feibiao, Hu, Chengyun, Li, Xue, Dong, Yongfei, Tang, Chaoliang. 2023. Cav3.2 channel regulates cerebral ischemia/reperfusion injury: a promising target for intervention. In Neural regeneration research, 19, 2480-2487. doi:10.4103/1673-5374.390966. https://pubmed.ncbi.nlm.nih.gov/38526284/
智鼠故事 
